| pubmed-article:10102909 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10102909 | lifeskim:mentions | umls-concept:C0007807 | lld:lifeskim |
| pubmed-article:10102909 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
| pubmed-article:10102909 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:10102909 | lifeskim:mentions | umls-concept:C0086045 | lld:lifeskim |
| pubmed-article:10102909 | lifeskim:mentions | umls-concept:C0003595 | lld:lifeskim |
| pubmed-article:10102909 | lifeskim:mentions | umls-concept:C0031437 | lld:lifeskim |
| pubmed-article:10102909 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:10102909 | pubmed:dateCreated | 1999-4-14 | lld:pubmed |
| pubmed-article:10102909 | pubmed:abstractText | Apolipoprotein (apo) E may be related to the development of Alzheimer disease, but data on apoE in cerebrospinal fluid (CSF) are limited. The aim of the present study was to measure apoE in CSF and relate its concentrations to apoE phenotype and CSF lipids. | lld:pubmed |
| pubmed-article:10102909 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10102909 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10102909 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10102909 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10102909 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10102909 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10102909 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10102909 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:10102909 | pubmed:issn | 0009-9147 | lld:pubmed |
| pubmed-article:10102909 | pubmed:author | pubmed-author:HidakaHH | lld:pubmed |
| pubmed-article:10102909 | pubmed:author | pubmed-author:YamauchiKK | lld:pubmed |
| pubmed-article:10102909 | pubmed:author | pubmed-author:KondoYY | lld:pubmed |
| pubmed-article:10102909 | pubmed:author | pubmed-author:NakabayashiTT | lld:pubmed |
| pubmed-article:10102909 | pubmed:author | pubmed-author:KatsuyamaTT | lld:pubmed |
| pubmed-article:10102909 | pubmed:author | pubmed-author:SuganoMM | lld:pubmed |
| pubmed-article:10102909 | pubmed:author | pubmed-author:TozukaMM | lld:pubmed |
| pubmed-article:10102909 | pubmed:copyrightInfo | Copyright 1999 American Association for Clinical Chemistry | lld:pubmed |
| pubmed-article:10102909 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10102909 | pubmed:volume | 45 | lld:pubmed |
| pubmed-article:10102909 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10102909 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10102909 | pubmed:pagination | 497-504 | lld:pubmed |
| pubmed-article:10102909 | pubmed:dateRevised | 2010-6-25 | lld:pubmed |
| pubmed-article:10102909 | pubmed:meshHeading | pubmed-meshheading:10102909... | lld:pubmed |
| pubmed-article:10102909 | pubmed:meshHeading | pubmed-meshheading:10102909... | lld:pubmed |
| pubmed-article:10102909 | pubmed:meshHeading | pubmed-meshheading:10102909... | lld:pubmed |
| pubmed-article:10102909 | pubmed:meshHeading | pubmed-meshheading:10102909... | lld:pubmed |
| pubmed-article:10102909 | pubmed:meshHeading | pubmed-meshheading:10102909... | lld:pubmed |
| pubmed-article:10102909 | pubmed:meshHeading | pubmed-meshheading:10102909... | lld:pubmed |
| pubmed-article:10102909 | pubmed:meshHeading | pubmed-meshheading:10102909... | lld:pubmed |
| pubmed-article:10102909 | pubmed:meshHeading | pubmed-meshheading:10102909... | lld:pubmed |
| pubmed-article:10102909 | pubmed:meshHeading | pubmed-meshheading:10102909... | lld:pubmed |
| pubmed-article:10102909 | pubmed:meshHeading | pubmed-meshheading:10102909... | lld:pubmed |
| pubmed-article:10102909 | pubmed:meshHeading | pubmed-meshheading:10102909... | lld:pubmed |
| pubmed-article:10102909 | pubmed:meshHeading | pubmed-meshheading:10102909... | lld:pubmed |
| pubmed-article:10102909 | pubmed:meshHeading | pubmed-meshheading:10102909... | lld:pubmed |
| pubmed-article:10102909 | pubmed:meshHeading | pubmed-meshheading:10102909... | lld:pubmed |
| pubmed-article:10102909 | pubmed:meshHeading | pubmed-meshheading:10102909... | lld:pubmed |
| pubmed-article:10102909 | pubmed:meshHeading | pubmed-meshheading:10102909... | lld:pubmed |
| pubmed-article:10102909 | pubmed:meshHeading | pubmed-meshheading:10102909... | lld:pubmed |
| pubmed-article:10102909 | pubmed:meshHeading | pubmed-meshheading:10102909... | lld:pubmed |
| pubmed-article:10102909 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10102909 | pubmed:articleTitle | Apolipoprotein E in cerebrospinal fluid: relation to phenotype and plasma apolipoprotein E concentrations. | lld:pubmed |
| pubmed-article:10102909 | pubmed:affiliation | Central Clinical Laboratories, Shinshu University Hospital, 3-1-1 Asahi, Matsumoto 390-8621, Japan. | lld:pubmed |
| pubmed-article:10102909 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10102909 | lld:pubmed |
